Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

NCT04091789 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pure Green